Aspen Group, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

Stockholders' Equity (Details)										1 Months Ended			3 Months Ended				9 Months Ended
Stockholders' Equity (Details)	Jan. 22, 2020 USD ($) $ / shares shares	Dec. 09, 2019 $ / shares shares	Nov. 30, 2019 USD ($)	Aug. 20, 2019 investor shares	Aug. 17, 2019 shares	Aug. 01, 2019 USD ($) subsidiary $ / shares shares	Jun. 18, 2019 shares	May 13, 2019 $ / shares shares	Dec. 24, 2018 USD ($) shares	Dec. 31, 2019 USD ($) shares	Nov. 30, 2019 USD ($) shares	Sep. 30, 2018 USD ($) $ / shares shares	Jan. 31, 2020 USD ($) shares	Oct. 31, 2019 USD ($) shares	Jul. 31, 2019 USD ($) shares	Jan. 31, 2019 USD ($) shares	Jan. 31, 2020 USD ($) shares	Jan. 31, 2019 USD ($) shares	Dec. 30, 2019 shares	Jun. 28, 2019 shares	Jun. 07, 2019 shares	Jun. 03, 2019 shares	Apr. 30, 2019 shares	Dec. 13, 2018 shares	Mar. 13, 2012 shares
Stockholders Equity [Line Items]
Preferred stock, shares authorized (in shares)													1,000,000				1,000,000						1,000,000
Preferred stock issued (in shares)													0				0						0
Preferred stock outstanding (in shares)													0				0						0
Common stock, shares authorized (in shares)													40,000,000				40,000,000						40,000,000
Common stock issued for stock options exercised for cash \| $													$ 530,668	$ 192,522	$ 45,190	$ 50,041	$ 768,381	$ 110,143
Proceeds from issuance of stock issued in equity raise \| $	$ 17,267,250																$ 16,044,879	$ 0
Common stock issued in equity raise (in dollars per share) \| $ / shares	$ 7.15
Net proceeds of equity issuance \| $	$ 16,044,879
Weighted average recognition period																	2 years
Restricted stock issued, fair value \| $													$ 0				$ 0
Number of investors electing cashless exercises \| investor				2
Common stock issued (in shares)													21,727,075				21,727,075						18,665,551
Compensation expense \| $													$ 805,405				$ 1,721,293
Unrecognized compensation costs \| $													$ 930,000				$ 930,000
Over-Allotment Option
Stockholders Equity [Line Items]
Sale of stock, number of share issued in transaction	315,000
Investor
Stockholders Equity [Line Items]
Restricted shares granted (in shares)																	25,000
Restricted shares granted, value \| $																	$ 122,250
Equity Incentive Plan
Stockholders Equity [Line Items]
Number of shares granted (in shares)													177,046				177,046
Number of shares authorized (in shares)																			1,100,000					500,000	3,500,000
Common stock, shares remaining for future issuance (in shares)													109,352				109,352
Common Stock
Stockholders Equity [Line Items]
Common stock issued for cashless stock options exercised (in shares)													8,352	80,313	101,894	55,871	190,559	86,635
Common stock issued for stock options exercised for cash (in shares)													121,407	90,950	21,876	22,985	234,233	49,792
Common stock issued for stock options exercised for cash \| $													$ 121			$ 23	$ 234	$ 49
Common stock issued for services (in shares)													25,000
Common stock issued for services \| $													$ 177,500
Restricted stock issued (in shares)													40,000				144,803
Common stock issued in equity raise (in shares)	2,415,000
Common stock issued for cashless warrant exercise (in shares)														57,526	19,403	35,921	76,929	35,921
Cashless exercise of warrants (in shares)														121,070	43,860
Restricted stock issued, fair value \| $													$ 40				$ 144
Common Stock \| Minimum
Stockholders Equity [Line Items]
Preferred stock, shares authorized (in shares)																				40,000,000
Common Stock \| Maximum
Stockholders Equity [Line Items]
Preferred stock, shares authorized (in shares)																				250,000,000
Preferred Stock \| Minimum
Stockholders Equity [Line Items]
Preferred stock, shares authorized (in shares)																				1,000,000
Preferred Stock \| Maximum
Stockholders Equity [Line Items]
Preferred stock, shares authorized (in shares)																				10,000,000
Warrant
Stockholders Equity [Line Items]
Unvested shares of restricted common stock outstanding (in shares)													226,922				226,922
Total unrecognized compensation expense \| $													$ 1,285,524				$ 1,285,524
Director
Stockholders Equity [Line Items]
Restricted stock issued (in shares)														30,131
Restricted stock issued, fair value \| $														$ 122,332
Former Director
Stockholders Equity [Line Items]
Common stock issued (in shares)																						9,806
Former Director \| Warrant
Stockholders Equity [Line Items]
Common stock issued (in shares)																						21,930
Chief Executive Officer
Stockholders Equity [Line Items]
Common stock issued (in shares)																					9,597
Chief Financial Officer \| Common Stock
Stockholders Equity [Line Items]
Common stock issued in equity raise (in shares)													15,000
Net proceeds of equity issuance \| $													$ 103,350
Investor 1
Stockholders Equity [Line Items]
Common stock issued for cashless warrant exercise (in shares)				8,970
Investor 1 \| Warrant
Stockholders Equity [Line Items]
Cashless exercise of warrants (in shares)				18,818
Investor 2
Stockholders Equity [Line Items]
Common stock issued for cashless warrant exercise (in shares)				42,285
Investor 2 \| Warrant
Stockholders Equity [Line Items]
Cashless exercise of warrants (in shares)				88,710
Investor
Stockholders Equity [Line Items]
Common stock issued for cashless warrant exercise (in shares)					6,271
Investor \| Warrant
Stockholders Equity [Line Items]
Cashless exercise of warrants (in shares)					13,542
Executive Officer
Stockholders Equity [Line Items]
Stock based compensation expense \| $													$ 188,031
Restricted Stock
Stockholders Equity [Line Items]
Number of shares granted (in shares)									24,672
Restricted stock vesting period									36 months
Restricted Stock \| Investor
Stockholders Equity [Line Items]
Restricted shares vested (in shares)													5,000				5,000
Restricted Stock \| Andrew Kaplan Current Director
Stockholders Equity [Line Items]
Granted (in shares)							5,131
Options granted (in shares)							5,131
Restricted Stock \| Two former directors
Stockholders Equity [Line Items]
Granted (in shares)							25,000
Options granted (in shares)							25,000
Restricted Stock \| Director
Stockholders Equity [Line Items]
Restricted shares granted, value \| $									$ 126,320
Restricted Stock \| Chief Financial Officer
Stockholders Equity [Line Items]
Total unrecognized compensation expense \| $												$ 180,000
Restricted shares granted (in shares)												25,000
Weighted average recognition period												36 months
Restricted stock price on date of grant (in dollars per share) \| $ / shares												$ 7.15
Vesting percentage of award			66.67%
Amortization \| $			$ 108,000
Non-qualified stock options to certain former directors
Stockholders Equity [Line Items]
Granted (in shares)								30,000
Options granted (in shares)								30,000
Fair value of stock options \| $															$ 33,600
Terms of share-based payment award								five years
Share-based payment award exercise price (in dollars per share) \| $ / shares								$ 4.12
Share-based Payment Arrangement, Option
Stockholders Equity [Line Items]
Granted (in shares)		61,000				59,000
Options granted (in shares)		61,000				59,000
Exercise price of options for services performed (in dollars per share) \| $ / shares		$ 6.92
Fair value of stock options \| $						$ 83,000							$ 116,000				$ 116,000
Options granted, number of employees \| subsidiary						26
Recognition period of stock options (in months)						36 months
Exercise price of options (in dollars per share) \| $ / shares						$ 3.99
Restricted Stock Units (RSUs)
Stockholders Equity [Line Items]
Weighted average recognition period										3 years
Fair value of RSUs \| $										$ 826,800
Restricted Stock Units (RSUs) \| Chief Financial Officer
Stockholders Equity [Line Items]
Restricted shares granted (in shares)										100,000	50,000
Weighted average recognition period											3 years
Fair value of RSUs \| $			314,500								$ 314,500
Restricted Stock Units (RSUs) \| Chief Accounting Officer
Stockholders Equity [Line Items]
Restricted shares granted (in shares)										20,000
Restricted Stock Units (RSUs) \| Employees
Stockholders Equity [Line Items]
Restricted shares granted (in shares)											17,250
Weighted average recognition period											3 years
Fair value of RSUs \| $			$ 108,500								$ 108,500